p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA Kit
5
(1 Review)
|
(7 Publications)
p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA Kit is a Cell-based ELISA for the measurement of p38 MAPK alpha (Thr180/Tyr182) In-Cell in Human, Mouse, Rat in Cell Samples samples.
View Alternative Names
CSBP, CSBP1, CSBP2, CSPB1, MXI2, SAPK2A, MAPK14, Mitogen-activated protein kinase 14, MAP kinase 14, MAPK 14, Cytokine suppressive anti-inflammatory drug-binding protein, MAP kinase MXI2, MAX-interacting protein 2, Mitogen-activated protein kinase p38 alpha, Stress-activated protein kinase 2a, CSAID-binding protein, MAP kinase p38 alpha, SAPK2a
- In-Cell ELISA
Unknown
In-Cell ELISA - p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA Kit (AB126425)
HeLa cells were stimulated by different concentrations of anisomycin for 15 minutes at 37°C.
- In-Cell ELISA
Unknown
In-Cell ELISA - p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA Kit (AB126425)
HeLa cells were stimulated by different concentrations of anisomycin for 1 hour at 37°C.
- WB
Supplier Data
Western blot - p38 MAPK alpha (Thr180/Tyr182) In-Cell ELISA Kit (AB126425)
Western blot analysis of extracts from 1 µg/ml Anisomycin treated HeLa cells. Phospho-p38 MAPK (Thr180/Tyr182) and Anti-p38 MAPK antibodies from ab126425 were used in both detection assays.
false
Reactivity data
Product details
ab126425 is a very rapid, convenient and sensitive assay kit that can monitor the activation or function of important biological pathways in cells. It can be used for measuring the relative amount of p38 MAPK (Thr180/Tyr182) phosphorylation and screening the effects of various treatments, inhibitors (such as siRNA or chemicals), or activators in cultured human, mouse and rat cell lines. By determining p38 MAPK protein phosphorylation in your experimental model system, you can verify pathway activation in your cell lines without spending excess time and effort in preparing cell lysate and performing an analysis of Western Blot.
In the p38 MAPK (Thr180/Tyr182) In-Cell ELISA Kit, cells are seeded into a 96 well tissue culture plate. The cells are fixed after various treatments, inhibitors or activators. After blocking, Anti-Phospho-p38 MAPK (Thr180/Tyr182) or Anti-p38 MAPK (primary antibody) is pipetted into the wells and incubated. The wells are washed, and HRP-conjugated anti-mouse IgG (secondary antibody) is added to the wells. The wells are washed again, a TMB substrate solution is added to the wells and color develops in proportion to the amount of protein. The Stop Solution changes the color from blue to yellow, and the intensity of the color is measured at 450 nm.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P38 alpha MAPK14 is a part of a larger mitogen-activated protein kinase (MAPK) complex where it serves to mediate signals from external stressors to the appropriate cellular processes. It is particularly active in its roles involving inflammation and apoptosis regulation. The protein interacts with other members of the MAPK family and additional proteins such as TAB1 to conduct these biological signals efficiently.
Pathways
P38 alpha integrates into the p38 MAPK pathway and the NF-kB signaling pathway which are essential for managing cellular stress responses and inflammatory reactions. It closely interacts with other proteins like MKK3 and MKK6 which are directly upstream regulators phosphorylating and activating p38 MAPK14. This intricate connection allows p38 alpha to execute precise regulation within cellular environments.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in pharmacology 12:728261 PubMed34526903
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oxidative medicine and cellular longevity 2021:8049079 PubMed33643519
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 11:532395 PubMed33390934
2020
Applications
Unspecified application
Species
Unspecified reactive species
European review for medical and pharmacological sciences 23:4398-4405 PubMed31173314
2019
Applications
Unspecified application
Species
Unspecified reactive species
Toxicology and applied pharmacology 340:67-76 PubMed29288688
2017
Applications
Unspecified application
Species
Human
Archiv der Pharmazie 350: PubMed28787092
2017
Applications
Unspecified application
Species
Unspecified reactive species
Molecular and cellular biochemistry 399:201-8 PubMed25318610
2014
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com